APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Mediated Tumor Killing Assays Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Immune Mediated Tumor Killing Assays Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 July 2026198 pages

Choose your research edition.

Industry ResearchImmune Mediated Tumor Killing Assays Service Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Mediated Tumor Killing Assays Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Immune Mediated Tumor Killing Assays Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Mediated Tumor Killing Assays Service Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Mediated Tumor Killing Assays Service Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Immune Mediated Tumor Killing Assays Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Immune Mediated Tumor Killing Assays Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immune Mediated Tumor Killing Assays Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune Mediated Tumor Killing Assays Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immune Mediated Tumor Killing Assays Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immune Mediated Tumor Killing Assays Service include Agilent, Laboratories, Explicyte, Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology and ProBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Immune Mediated Tumor Killing Assays Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immune Mediated Tumor Killing Assays Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune Mediated Tumor Killing Assays Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Immune Mediated Tumor Killing Assays Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Immune Mediated Tumor Killing Assays Service Segment by Company

Agilent

Laboratories

Explicyte

Reaction Biology

Axion BioSystems

Sartorius

ICE Bioscience

Shanghai Saily Biotechnology

ProBio

Charles River

Imodels

Xeno Diagnostics

Cyagen

MarinBio

Pharmalegacy

Celentyx

Crown Bioscience

Cellomatics Biosciences

Immune Mediated Tumor Killing Assays Service Segment by Type

Cytotoxic T Cell Assay

Natural Killer (NK) Cell Assay

Other

Immune Mediated Tumor Killing Assays Service Segment by Application

Cancer Research

Infectious Disease Research

Immunotherapy Development

Immune Mediated Tumor Killing Assays Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Mediated Tumor Killing Assays Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Mediated Tumor Killing Assays Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Mediated Tumor Killing Assays Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Immune Mediated Tumor Killing Assays Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune Mediated Tumor Killing Assays Service industry.

Chapter 3: Detailed analysis of Immune Mediated Tumor Killing Assays Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Mediated Tumor Killing Assays Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cytotoxic T Cell Assay Table 3. Key Players of Natural Killer (NK) Cell Assay Table 4. Key Players of Other Table 4. Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Research Table 6. Key Players of Infectious Disease Research Table 7. Key Players of Immunotherapy Development Table 8. Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Immune Mediated Tumor Killing Assays Service Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Immune Mediated Tumor Killing Assays Service Market Share by Region (2021-2026) Table 11. Global Immune Mediated Tumor Killing Assays Service Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Immune Mediated Tumor Killing Assays Service Market Share by Region (2027-2032) Table 13. Immune Mediated Tumor Killing Assays Service Industry Trends Table 14. Immune Mediated Tumor Killing Assays Service Industry Drivers Table 15. Immune Mediated Tumor Killing Assays Service Industry Opportunities and Challenges Table 16. Immune Mediated Tumor Killing Assays Service Industry Restraints Table 17. Global Immune Mediated Tumor Killing Assays Service Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Company (2021-2026) Table 19. Global Immune Mediated Tumor Killing Assays Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Immune Mediated Tumor Killing Assays Service Key Company Head Office and Area Served Table 21. Global Immune Mediated Tumor Killing Assays Service Company, Product Type & Application Table 22. Global Immune Mediated Tumor Killing Assays Service Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Immune Mediated Tumor Killing Assays Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Immune Mediated Tumor Killing Assays Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Type (2021-2026) Table 29. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Type (2027-2032) Table 30. Global Immune Mediated Tumor Killing Assays Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Application (2021-2026) Table 34. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Application (2027-2032) Table 35. Agilent Company Information Table 36. Agilent Business Overview Table 37. Agilent Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Agilent Immune Mediated Tumor Killing Assays Service Product Portfolio Table 39. Agilent Recent Development Table 40. Laboratories Company Information Table 41. Laboratories Business Overview Table 42. Laboratories Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Laboratories Immune Mediated Tumor Killing Assays Service Product Portfolio Table 44. Laboratories Recent Development Table 45. Explicyte Company Information Table 46. Explicyte Business Overview Table 47. Explicyte Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Explicyte Immune Mediated Tumor Killing Assays Service Product Portfolio Table 49. Explicyte Recent Development Table 50. Reaction Biology Company Information Table 51. Reaction Biology Business Overview Table 52. Reaction Biology Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Reaction Biology Immune Mediated Tumor Killing Assays Service Product Portfolio Table 54. Reaction Biology Recent Development Table 55. Axion BioSystems Company Information Table 56. Axion BioSystems Business Overview Table 57. Axion BioSystems Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Axion BioSystems Immune Mediated Tumor Killing Assays Service Product Portfolio Table 59. Axion BioSystems Recent Development Table 60. Sartorius Company Information Table 61. Sartorius Business Overview Table 62. Sartorius Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sartorius Immune Mediated Tumor Killing Assays Service Product Portfolio Table 64. Sartorius Recent Development Table 65. ICE Bioscience Company Information Table 66. ICE Bioscience Business Overview Table 67. ICE Bioscience Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. ICE Bioscience Immune Mediated Tumor Killing Assays Service Product Portfolio Table 69. ICE Bioscience Recent Development Table 70. Shanghai Saily Biotechnology Company Information Table 71. Shanghai Saily Biotechnology Business Overview Table 72. Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Product Portfolio Table 74. Shanghai Saily Biotechnology Recent Development Table 75. ProBio Company Information Table 76. ProBio Business Overview Table 77. ProBio Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. ProBio Immune Mediated Tumor Killing Assays Service Product Portfolio Table 79. ProBio Recent Development Table 80. Charles River Company Information Table 81. Charles River Business Overview Table 82. Charles River Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Charles River Immune Mediated Tumor Killing Assays Service Product Portfolio Table 84. Charles River Recent Development Table 85. Imodels Company Information Table 86. Imodels Business Overview Table 87. Imodels Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Imodels Immune Mediated Tumor Killing Assays Service Product Portfolio Table 89. Imodels Recent Development Table 90. Xeno Diagnostics Company Information Table 91. Xeno Diagnostics Business Overview Table 92. Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Product Portfolio Table 94. Xeno Diagnostics Recent Development Table 95. Cyagen Company Information Table 96. Cyagen Business Overview Table 97. Cyagen Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Cyagen Immune Mediated Tumor Killing Assays Service Product Portfolio Table 99. Cyagen Recent Development Table 100. MarinBio Company Information Table 101. MarinBio Business Overview Table 102. MarinBio Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. MarinBio Immune Mediated Tumor Killing Assays Service Product Portfolio Table 104. MarinBio Recent Development Table 105. Pharmalegacy Company Information Table 106. Pharmalegacy Business Overview Table 107. Pharmalegacy Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Pharmalegacy Immune Mediated Tumor Killing Assays Service Product Portfolio Table 109. Pharmalegacy Recent Development Table 110. Celentyx Company Information Table 111. Celentyx Business Overview Table 112. Celentyx Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Celentyx Immune Mediated Tumor Killing Assays Service Product Portfolio Table 114. Celentyx Recent Development Table 115. Crown Bioscience Company Information Table 116. Crown Bioscience Business Overview Table 117. Crown Bioscience Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Crown Bioscience Immune Mediated Tumor Killing Assays Service Product Portfolio Table 119. Crown Bioscience Recent Development Table 120. Cellomatics Biosciences Company Information Table 121. Cellomatics Biosciences Business Overview Table 122. Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Product Portfolio Table 124. Cellomatics Biosciences Recent Development Table 125. North America Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026) & (US$ Million) Table 126. North America Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032) & (US$ Million) Table 127. North America Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026) & (US$ Million) Table 128. North America Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032) & (US$ Million) Table 129. North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) Table 131. North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2027-2032) Table 132. Europe Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026) & (US$ Million) Table 133. Europe Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032) & (US$ Million) Table 134. Europe Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026) & (US$ Million) Table 135. Europe Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032) & (US$ Million) Table 136. Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) Table 138. Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2027-2032) Table 139. China Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026) & (US$ Million) Table 140. China Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032) & (US$ Million) Table 141. China Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026) & (US$ Million) Table 142. China Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026) & (US$ Million) Table 144. Asia Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032) & (US$ Million) Table 145. Asia Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026) & (US$ Million) Table 146. Asia Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Immune Mediated Tumor Killing Assays Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) Table 149. Asia Immune Mediated Tumor Killing Assays Service Market Size by Country (2027-2032) Table 150. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) Table 156. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Immune Mediated Tumor Killing Assays Service Product Image Figure 2. Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Immune Mediated Tumor Killing Assays Service Market Share by Type: 2025 VS 2032 Figure 4. Cytotoxic T Cell Assay Image Figure 5. Natural Killer (NK) Cell Assay Image Figure 6. Other Image Figure 7. Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Immune Mediated Tumor Killing Assays Service Market Share by Application: 2025 VS 2032 Figure 9. Cancer Research Image Figure 10. Infectious Disease Research Image Figure 11. Immunotherapy Development Image Figure 12. Global Immune Mediated Tumor Killing Assays Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 14. Global Immune Mediated Tumor Killing Assays Service Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Immune Mediated Tumor Killing Assays Service Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Immune Mediated Tumor Killing Assays Service Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Immune Mediated Tumor Killing Assays Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Type (2021-2032) Figure 21. Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Application (2021-2032) Figure 23. North America Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 24. North America Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032) Figure 25. North America Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032) Figure 26. North America Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 27. United States Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 28. Canada Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 30. Europe Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032) Figure 32. Europe Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032) Figure 33. Europe Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 34. Germany Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 35. France Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 37. Italy Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 38. Russia Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 40. China Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 41. China Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032) Figure 42. China Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032) Figure 43. Asia Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 44. Asia Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032) Figure 45. Asia Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032) Figure 46. Asia Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 47. Japan Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 51. India Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 52. Australia Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 57. Brazil Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 62. UAE Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 64. Chile Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Cytotoxic T Cell Assay
  • Natural Killer (NK) Cell Assay
  • Other
Applications
  • Cancer Research
  • Infectious Disease Research
  • Immunotherapy Development
Companies covered
  • Agilent
  • Laboratories
  • Explicyte
  • Reaction Biology
  • Axion BioSystems
  • Sartorius
  • ICE Bioscience
  • Shanghai Saily Biotechnology
  • ProBio
  • Charles River
  • Imodels
  • Xeno Diagnostics
  • Cyagen
  • MarinBio
  • Pharmalegacy
  • Celentyx
  • Crown Bioscience
  • Cellomatics Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cytotoxic T Cell Assay
  5. 1.2.3 Natural Killer (NK) Cell Assay
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer Research
  10. 1.3.3 Infectious Disease Research
  11. 1.3.4 Immunotherapy Development
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Immune Mediated Tumor Killing Assays Service Growth Trends by Region
  14. 1.5.1 Global Immune Mediated Tumor Killing Assays Service Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Immune Mediated Tumor Killing Assays Service Market Size by Region (2021-2026)
  16. 1.5.3 Immune Mediated Tumor Killing Assays Service Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Immune Mediated Tumor Killing Assays Service Market Dynamics
  1. 2.1 Immune Mediated Tumor Killing Assays Service Industry Trends
  2. 2.2 Immune Mediated Tumor Killing Assays Service Industry Drivers
  3. 2.3 Immune Mediated Tumor Killing Assays Service Industry Opportunities and Challenges
  4. 2.4 Immune Mediated Tumor Killing Assays Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Immune Mediated Tumor Killing Assays Service Revenue by Company (2021-2026)
  2. 3.2 Global Immune Mediated Tumor Killing Assays Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Immune Mediated Tumor Killing Assays Service Key Company Head office and Area Served
  4. 3.4 Global Immune Mediated Tumor Killing Assays Service Company, Product Type & Application
  5. 3.5 Global Immune Mediated Tumor Killing Assays Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Immune Mediated Tumor Killing Assays Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Immune Mediated Tumor Killing Assays Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Immune Mediated Tumor Killing Assays Service Tier 1, Tier 2, and Tier 3
4 Immune Mediated Tumor Killing Assays Service Market by Type
  1. 4.1 Global Immune Mediated Tumor Killing Assays Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2032)
  3. 4.3 Global Immune Mediated Tumor Killing Assays Service Market Size Share by Type (2021-2032)
5 Immune Mediated Tumor Killing Assays Service Market by Application
  1. 5.1 Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2032)
  3. 5.3 Global Immune Mediated Tumor Killing Assays Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Agilent
  2. 6.1.1 Agilent Company Information
  3. 6.1.2 Agilent Business Overview
  4. 6.1.3 Agilent Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Agilent Immune Mediated Tumor Killing Assays Service Product Portfolio
  6. 6.1.5 Agilent Recent Developments
  7. 6.2 Laboratories
  8. 6.2.1 Laboratories Company Information
  9. 6.2.2 Laboratories Business Overview
  10. 6.2.3 Laboratories Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Laboratories Immune Mediated Tumor Killing Assays Service Product Portfolio
  12. 6.2.5 Laboratories Recent Developments
  13. 6.3 Explicyte
  14. 6.3.1 Explicyte Company Information
  15. 6.3.2 Explicyte Business Overview
  16. 6.3.3 Explicyte Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Explicyte Immune Mediated Tumor Killing Assays Service Product Portfolio
  18. 6.3.5 Explicyte Recent Developments
  19. 6.4 Reaction Biology
  20. 6.4.1 Reaction Biology Company Information
  21. 6.4.2 Reaction Biology Business Overview
  22. 6.4.3 Reaction Biology Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Reaction Biology Immune Mediated Tumor Killing Assays Service Product Portfolio
  24. 6.4.5 Reaction Biology Recent Developments
  25. 6.5 Axion BioSystems
  26. 6.5.1 Axion BioSystems Company Information
  27. 6.5.2 Axion BioSystems Business Overview
  28. 6.5.3 Axion BioSystems Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Axion BioSystems Immune Mediated Tumor Killing Assays Service Product Portfolio
  30. 6.5.5 Axion BioSystems Recent Developments
  31. 6.6 Sartorius
  32. 6.6.1 Sartorius Company Information
  33. 6.6.2 Sartorius Business Overview
  34. 6.6.3 Sartorius Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Sartorius Immune Mediated Tumor Killing Assays Service Product Portfolio
  36. 6.6.5 Sartorius Recent Developments
  37. 6.7 ICE Bioscience
  38. 6.7.1 ICE Bioscience Company Information
  39. 6.7.2 ICE Bioscience Business Overview
  40. 6.7.3 ICE Bioscience Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ICE Bioscience Immune Mediated Tumor Killing Assays Service Product Portfolio
  42. 6.7.5 ICE Bioscience Recent Developments
  43. 6.8 Shanghai Saily Biotechnology
  44. 6.8.1 Shanghai Saily Biotechnology Company Information
  45. 6.8.2 Shanghai Saily Biotechnology Business Overview
  46. 6.8.3 Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Product Portfolio
  48. 6.8.5 Shanghai Saily Biotechnology Recent Developments
  49. 6.9 ProBio
  50. 6.9.1 ProBio Company Information
  51. 6.9.2 ProBio Business Overview
  52. 6.9.3 ProBio Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 ProBio Immune Mediated Tumor Killing Assays Service Product Portfolio
  54. 6.9.5 ProBio Recent Developments
  55. 6.10 Charles River
  56. 6.10.1 Charles River Company Information
  57. 6.10.2 Charles River Business Overview
  58. 6.10.3 Charles River Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Charles River Immune Mediated Tumor Killing Assays Service Product Portfolio
  60. 6.10.5 Charles River Recent Developments
  61. 6.11 Imodels
  62. 6.11.1 Imodels Company Information
  63. 6.11.2 Imodels Business Overview
  64. 6.11.3 Imodels Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Imodels Immune Mediated Tumor Killing Assays Service Product Portfolio
  66. 6.11.5 Imodels Recent Developments
  67. 6.12 Xeno Diagnostics
  68. 6.12.1 Xeno Diagnostics Company Information
  69. 6.12.2 Xeno Diagnostics Business Overview
  70. 6.12.3 Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Product Portfolio
  72. 6.12.5 Xeno Diagnostics Recent Developments
  73. 6.13 Cyagen
  74. 6.13.1 Cyagen Company Information
  75. 6.13.2 Cyagen Business Overview
  76. 6.13.3 Cyagen Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Cyagen Immune Mediated Tumor Killing Assays Service Product Portfolio
  78. 6.13.5 Cyagen Recent Developments
  79. 6.14 MarinBio
  80. 6.14.1 MarinBio Company Information
  81. 6.14.2 MarinBio Business Overview
  82. 6.14.3 MarinBio Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 MarinBio Immune Mediated Tumor Killing Assays Service Product Portfolio
  84. 6.14.5 MarinBio Recent Developments
  85. 6.15 Pharmalegacy
  86. 6.15.1 Pharmalegacy Company Information
  87. 6.15.2 Pharmalegacy Business Overview
  88. 6.15.3 Pharmalegacy Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Pharmalegacy Immune Mediated Tumor Killing Assays Service Product Portfolio
  90. 6.15.5 Pharmalegacy Recent Developments
  91. 6.16 Celentyx
  92. 6.16.1 Celentyx Company Information
  93. 6.16.2 Celentyx Business Overview
  94. 6.16.3 Celentyx Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Celentyx Immune Mediated Tumor Killing Assays Service Product Portfolio
  96. 6.16.5 Celentyx Recent Developments
  97. 6.17 Crown Bioscience
  98. 6.17.1 Crown Bioscience Company Information
  99. 6.17.2 Crown Bioscience Business Overview
  100. 6.17.3 Crown Bioscience Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Crown Bioscience Immune Mediated Tumor Killing Assays Service Product Portfolio
  102. 6.17.5 Crown Bioscience Recent Developments
  103. 6.18 Cellomatics Biosciences
  104. 6.18.1 Cellomatics Biosciences Company Information
  105. 6.18.2 Cellomatics Biosciences Business Overview
  106. 6.18.3 Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Product Portfolio
  108. 6.18.5 Cellomatics Biosciences Recent Developments
7 North America
  1. 7.1 North America Immune Mediated Tumor Killing Assays Service Market Size (2021-2032)
  2. 7.2 North America Immune Mediated Tumor Killing Assays Service Market Size by Type
  3. 7.2.1 North America Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032)
  6. 7.3 North America Immune Mediated Tumor Killing Assays Service Market Size by Application
  7. 7.3.1 North America Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032)
  10. 7.4 North America Immune Mediated Tumor Killing Assays Service Market Size by Country
  11. 7.4.1 North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Immune Mediated Tumor Killing Assays Service Market Size (2021-2032)
  2. 8.2 Europe Immune Mediated Tumor Killing Assays Service Market Size by Type
  3. 8.2.1 Europe Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032)
  6. 8.3 Europe Immune Mediated Tumor Killing Assays Service Market Size by Application
  7. 8.3.1 Europe Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032)
  10. 8.4 Europe Immune Mediated Tumor Killing Assays Service Market Size by Country
  11. 8.4.1 Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Immune Mediated Tumor Killing Assays Service Market Size (2021-2032)
  2. 9.2 China Immune Mediated Tumor Killing Assays Service Market Size by Type
  3. 9.2.1 China Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026)
  4. 9.2.2 China Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032)
  5. 9.2.3 China Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032)
  6. 9.3 China Immune Mediated Tumor Killing Assays Service Market Size by Application
  7. 9.3.1 China Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026)
  8. 9.3.2 China Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032)
  9. 9.3.3 China Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Immune Mediated Tumor Killing Assays Service Market Size (2021-2032)
  2. 10.2 Asia Immune Mediated Tumor Killing Assays Service Market Size by Type
  3. 10.2.1 Asia Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032)
  6. 10.3 Asia Immune Mediated Tumor Killing Assays Service Market Size by Application
  7. 10.3.1 Asia Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032)
  10. 10.4 Asia Immune Mediated Tumor Killing Assays Service Market Size by Country
  11. 10.4.1 Asia Immune Mediated Tumor Killing Assays Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Immune Mediated Tumor Killing Assays Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst